Bulletin
Investor Alert

New York Markets Open in:

Corbus Pharmaceuticals Holdings Inc.

NAS: CRBP

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 12, 2020, 7:59 p.m.

/zigman2/quotes/201549545/composite

$

7.29

Change

+0.18 +2.53%

Volume

Volume 16,209

Quotes are delayed by 20 min

/zigman2/quotes/201549545/composite

Previous close

$ 6.96

$ 7.11

Change

+0.15 +2.16%

Day low

Day high

$7.01

$7.37

Open

52 week low

52 week high

$3.29

$8.78

Open

Annual Financials for Corbus Pharmaceuticals Holdings Inc.

Fiscal year is January-December. All values USD millions. 20152016201720182019 5-year trend
Sales/Revenue 648,3821.91M2.44M4.82M36.14M
Cost of Goods Sold (COGS) incl. D&A -----
COGS excluding D&A -----
Depreciation & Amortization Expense 43,94387,664255,652493,9381.23M
Depreciation 43,94387,664255,652493,9381.23M
Amortization of Intangibles -----
Gross Income -----
20152016201720182019 5-year trend
SG&A Expense 9.46M21.81M34.75M61.08M116.6M
Research & Development 5.89M15.44M26.04M48.61M94.19M
Other SG&A 3.57M6.37M8.71M12.46M22.41M
Other Operating Expense -----
Unusual Expense ---191,244-
EBIT after Unusual Expense ---(56.94M)-
Non Operating Income/Expense 1,980(14,090)(41,910)284,0404.42M
Non-Operating Interest Income 3,4174,878196,487990,2081.25M
Equity in Affiliates (Pretax) -----
Interest Expense 2,4404,40113,3757,43119,025
Gross Interest Expense 2,4404,40113,3757,43119,025
Interest Capitalized -----
Pretax Income (8.85M)(20M)(32.42M)(55.67M)(76.04M)
Income Tax ----(4.58M)
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits ----4.58M
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (8.85M)(20M)(32.42M)(55.67M)(71.45M)
Minority Interest Expense -----
Net Income (8.85M)(20M)(32.42M)(55.67M)(71.45M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (8.85M)(20M)(32.42M)(55.67M)(71.45M)
Preferred Dividends -----
Net Income Available to Common (8.85M)(20M)(32.42M)(55.67M)(71.45M)
EPS (Basic) (0.28)(0.49)(0.65)(0.98)(1.12)
Basic Shares Outstanding 31.35M41.14M50.18M57M63.9M
EPS (Diluted) (0.28)(0.49)(0.65)(0.98)(1.12)
Diluted Shares Outstanding 31.35M41.14M50.18M57M63.9M
EBITDA (8.81M)(19.9M)(32.31M)(56.25M)(80.46M)
Link to MarketWatch's Slice.